Fesoterodine

Chemical formula: C₂₆H₃₇NO₃ Molecular mass: 411.577 g/mol PubChem compound: 6918558

Therapeutic indications

Fesoterodine is indicated for:

Overactive bladder syndrome

Population group: only adults (18 years old or older)

Fesoterodine is indicated in adults for treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur with overactive bladder syndrome.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

4-8 mg once daily

Contraindications

Fesoterodine is contraindicated in the following cases:

Pregnancy

Lactation

Severe hepatic impairment (Child Pugh C)

Hepatic failure stage IV

Urinary retention

Retention of urine

Gastric retention

Uncontrolled narrow angle glaucoma

Angle-closure glaucoma

Myasthenia gravis

Concomitant use of potent CYP3A4 inhibitors in subjects with moderate to severe hepatic or renal impairment

Strong CYP3A4 inhibitors and additionally at least one of

Hepatic failure stage III
Hepatic failure stage IV

Severe ulcerative colitis

Severe chronic ulcerative colitis

Toxic megacolon

† Toxic megacolon

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.